-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G2yDCHfuaKJWEw2v6gS+E0dmVJQI5NwPMuELXi3KjbEK5OWSRjotqz8fq8x91IwM YrR3kAsiaw1mc8mQ/ewhig== 0001144204-10-004426.txt : 20100129 0001144204-10-004426.hdr.sgml : 20100129 20100129135552 ACCESSION NUMBER: 0001144204-10-004426 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091031 FILED AS OF DATE: 20100129 DATE AS OF CHANGE: 20100129 EFFECTIVENESS DATE: 20100129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CardioGenics Holdings Inc. CENTRAL INDEX KEY: 0001089029 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 880380456 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-28761 FILM NUMBER: 10557003 BUSINESS ADDRESS: STREET 1: 6865 SW 18TH STREET SUITE B13 CITY: BACA RATON STATE: FL ZIP: 33433 BUSINESS PHONE: 905.673.8501 MAIL ADDRESS: STREET 1: 6295 NORTHAM DRIVE, STREET 2: UNIT 8 CITY: MISSISSAUGA, STATE: A6 ZIP: L4V 1W8 FORMER COMPANY: FORMER CONFORMED NAME: JAG MEDIA HOLDINGS INC DATE OF NAME CHANGE: 20020409 FORMER COMPANY: FORMER CONFORMED NAME: JAGNOTES COM DATE OF NAME CHANGE: 19990722 NT 10-K 1 v172693_nt10k.htm Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 12b-25
 
SEC File Number: 000-28761
CUSIP Number: 14160X 104

NOTIFICATION OF LATE FILING
 
(Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form N-SAR
o Form N-CSR
   
  For Period Ended: Fiscal Year ended October 31, 2009
   
  o Transition Report on Form 10-K
  o Transition Report on Form 20-F
  o Transition Report on Form 11-K
  o Transition Report on Form 10-Q
  o Transition Report on Form N-SAR
   
 
For the Transition Period Ended: ________________________
 
Read attached instruction sheet before preparing form. Please print or type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
______________________________________________________________________________

PART I -- REGISTRANT INFORMATION

CardioGenics Holdings Inc.
Full name of registrant:

Former name if applicable:

6295 Northam Drive, Unit 8
Address of principal executive office (Street and number):

Mississauga, Ontario L4V 1WB
City, state and zip code


PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)
 
x
(a)
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
     
x
(b)
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
     
 
(c)
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
PART III -- NARRATIVE
 
State below in reasonable detail the reasons why Forms 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof could not be filed within the prescribed time period.  (Attach extra sheets if needed).

Records and documentation necessary for completion of the narrative and financial statements for the report were not available in time to complete the Form 10-K of the Registrant for the fiscal year ending October 31, 2009.  The Registrant will file such report on or before February 15, 20010.
 
PART IV -- OTHER INFORMATION
 
(1) Name and telephone number of person to contact in regard to this notification
 
  Yahia Gawad  
(905)
   673-8501
  (Name)  
(Area Code)
   (Telephone Number)
 
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
   
 
x Yes o No
   
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
   
 
o Yes x No
 
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 
CardioGenics Holdings Inc.
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     
Date: January 29, 2009 By:   /s/ Yahia Gawad
 
Name: Yahia Gawad
 
Title: Chief Executive Officer
-----END PRIVACY-ENHANCED MESSAGE-----